Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation

Journal of the American College of Cardiology

Volumn 27, Issue 6, 1996, Pages 1464-1470

  Oskarsson, Helgi J ^a,b   Hofmeyer, Timothy G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE; VASODILATATION; VASOMOTOR REFLEX;

EID: 0029881608     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00019-8     Document Type: Article

References (38)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979;241:2035-8.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
3. Woods KL, Samanta A, Gurden AC. Diabetes mellitus as a risk factor for acute myocardial infarction in Asians and Europeans. Br Heart J 1989;62: 118-22.
4. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
5. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
6. Vincent GM, Anderson JL, Marshall HW. Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 1983;309: 220-3.
7. Cipriano PR, Koch FH, Rosenthal SMK, et al. Myocardial infarction in patients with coronary artery spasm demonstrated by angiography. Am Heart J 1983;105:542-7.
8. Shaw S, Pegrum GD, Wolff SS, Ashton WL. Platelet adhesiveness in diabetes mellitus. J Clin Pathol 1967;20:845-7.
9. Mayne EE, Bridges JM, Weaver JA. Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia 1970;6:436-40.
10. Menys VS, Bhatnagar D, Mackness MI, Durrington PN. Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemia. Atherosclerosis 1995;112:115-22.
11. Butkus A, Skrinska VA, Schumacker P. Thromboxane production and platelet aggregation in diabetic patients with clinical complications. Tromb Res 1980;19:211-23.
12. Catalano DG, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990;322:1769-74.
13. Winocour PD, Halushka PV, Colwell JA. Platelet involvement in diabetes mellitus. In: Longenecker GL, editor. The Platelets: Physiology and Pharmacology. New York: Academic Press, 1985:341-66.
14. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41 Suppl 2:26-31.
15. Hendra T, Betteridge DJ. Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 1989;35:197-212.
16. Shukla SD, Paul A, Klachko DM. Hypersensitivity of diabetic human platelets to platelet activating factor. Thromb Res 1992;66:239-46.
17. Betteridge DJ, Zahavi J, Jones NAG, et al. Platelet function in diabetes in relationship to complications, glycosylated haemoglobin and serum lipoproteins. Eur J Clin Invest 1981;111:272-7.
18. Paulsen EP, McChung NM, Sabio H. Some characteristics of spontaneous platelet aggregation in young insulin dependent diabetic subjects. Horm Metab Res Suppl 1981;11:15-21.
19. Burrows AW, Chavin S, Hockaday TDR. Plasma beta-thromboglobulin concentrations in diabetes mellitus. Lancet 1978;1:235-7.
20. Kaul S, Padgett RC, Waack BJ, Brooks RM, Heistad DD. Effect of atherosclerosis on responses of the perfused rabbit carotid artery to human platelets. Arterioscler Thromb 1992;12:1206-13.
21. Förstermann U, Mugge A, Bode SM, Frölich JC. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 1988;63:306-12.
22. Kaul S, Waack BJ, Padgett RC, Brooks RM, Heistad DD. Altered vascular responses to platelets from hypercholesterolemic humans. Circ Res 1993;72: 737-43.
23. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
24. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
25. Abiru T, Watanabe Y, Kamata K, Miyata N, Kasuya Y. Decrease in endothelium-dependent relaxation and levels of cyclic nucleotides in aorta from rabbits with alloxan-induced diabetes. Res Commun Chem Pathol Pharmacol 1990;68:13-25.
26. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol 1989;256:H621-H625.
27. Czervionke RL, Hoak JC, Fry GL. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel. J Clin Invest 1978;62:847-56.
28. Murer EH, Gyda MA, Martinez NJ. Insulin increases the aggregation response of human platelets to ADP. Thromb Res 1994;73:69-74.
29. Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab 1993;76:549-53.
30. Trovati M, Massucco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G. Insulin increases guanosine-3′,5′-cyclic monophosphate in human platelets. Diabetes 1994;43:1015-9.
31. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 1991;18:II90-9.
32. Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993;328:628-35.
33. Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991;26:H1043-H1052.
34. Durane W, Droll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992;79:110-6.
35. Kaul S, Naqvi TZ, Fishbein MC, et al. Profound inhibition of arterial thrombosis by a novel nitric oxide donor. J Am Coll Cardiol 1995;25:34A.
36. Kitagawa S, Fujisawa H, Kametani F, Sakurai H. Generation of active oxygen species in blood platelets - spin trapping analysis. Free Radie Res Comms 1992;15:319-24.
37. Iuliano L, Pedersen JZ, Pratico D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem 1994;221:695-704.
38. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 1986;320: 454-6.